Formycon’s Acquisition of the Biosimilar Candidates FYB201 and FYB202

DLA Piper has advised Active Ownership Capital as anchor shareholder of Formycon on the deal. honert, Norton Rose Fulbright, Baumann Inderkum & Muheim and Ashurst advised…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Laura Testa

Author: Laura Testa

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here